Over the past three months, SCYNEXIS Inc. [SCYX] ended the trading day at $6.68 and exhibited a change of 16.99% with a 24 hour trading and reached upto the volume of 73.03K compared to its recorded trading volume of 0.29 million. SCYX generated a 1 year amount change with -39.82%. Though for Principal markets a year is counted as a long time period. By having a look at the most recent performance of this stock, in the last week its amount moved by 22.34% with an amount shift of 35.77% over the last month.

On 6, November 2020, SCYNEXIS Reports Third Quarter 2020 Financial Results and Provides Company Update. According to news published on Yahoo Finance, In October, SCYNEXIS submitted a New Drug Application (NDA) for ibrexafungerp for the treatment of vulvovaginal candidiasis (VVC) with expected approval in mid-2021. .

Analyst Birdseye View:

The most recent analyst activity for SCYNEXIS Inc. [NASDAQ:SCYX] stock was on June 27, 2018, when it was Initiated with a Buy rating from Maxim Group, which also raised its 12-month price target on the stock to $6. Before that, on July 11, 2018, Needham Recapitulated a Buy rating and elevated its amount target to $5. On October 24, 2017, Guggenheim Initiated a Buy rating and boosted its price target on this stock to $6. On July 10, 2017, ROTH Capital Initiated a Buy rating and increased its price target to $8.50. On May 09, 2017, Needham Downgrade a Hold rating. On March 03, 2017, RBC Capital Mkts Reiterated an Outperform rating and boosted its amount target on this stock to $11. On October 20, 2016, H.C. Wainwright Initiated a Buy rating and boosted its target amount on this stock to $14. On October 07, 2016, WBB Securities Upgrade a Strong buy rating and amplified its amount target to $8.

In the past 52 weeks of trading, this stock has oscillated between a low of $4.20 and a peak of $12.10. Right now, the middling Wall Street analyst 12-month amount mark is $35.00. At the most recent market close, shares of SCYNEXIS Inc. [NASDAQ:SCYX] were valued at $6.68.

FUNDAMENTAL ANALYSIS

This publicly-traded organization’s revenue is $4,481 per employee, while its income is -$1,989,259 per employee. Continuing to look at profitability, this corporation’s Return on Assets, Equity, Whole Principal & invested Principal is sitting at -97.37, -243.47, -132.07 and -145.06 respectively.

The Principal structure of this organization shows its whole liability to whole principal at 53.58 and the whole liability to whole assets at 26.04. It shows enduring liability to the whole principal at 53.45 and enduring liability to assets at 0.26 while looking for an extended time period.

Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 6.04 points at 1st support level, the second support level is making up to 5.39. But as of 1st resistance point, this stock is sitting at 7.01 and at 7.33 for 2nd resistance point.

SCYNEXIS Inc. [SCYX] reported its earnings at $0.09 per share in the fiscal quarter closing of 9/29/2020. The Analysts for Wall Street were expecting to report its earnings at -$1.09/share signifying the difference of 1.18 and 108.30% surprise value. Comparing the previous quarter ending of 6/29/2020, the stated earnings were -$0.64 calling estimates for -$1.19/share with the difference of 0.55 depicting the surprise of 46.20%.

Important Ratio’s To Watch

Meanwhile, turning our focus to liquidity, the Current Ratio for SCYNEXIS Inc. [NASDAQ:SCYX] is 3.90. Likewise, the Quick ratio is also the same, showing Cash ratio at 4.40. Now if looking for a valuation of this stock’s amount to sales ratio it’s 421.77 and it’s amount to book ratio is 6.87.

Insider Stories

The most recent insider trade was by Taglietti Marco, Chief Executive Officer, and it was the purchase of 0.17 million shares on Dec 12.